Conclusion:
The use of next generation sequencing has significantly changed our
understanding of molecular oncogenic mechanisms of lung cancer. These
advancements have created a paradigm shift in the treatment strategies
of metastatic lung cancer from primarily chemotherapeutic approach to
increasing use of targeted therapies and immunecheckpointinhibitors
(ICI) leading to better survival rates and lesser toxicity.